Cargando…
Transcriptomic analysis identifies differences in gene expression in actinic keratoses after treatment with imiquimod and between responders and non responders
The presence of actinic keratoses (AKs) increases a patient’s risk of developing squamous cell carcinoma by greater than six-fold. We evaluated the effect of topical treatment with imiquimod on the tumor microenvironment by measuring transcriptomic differences in AKs before and after treatment with...
Autores principales: | Trager, Megan H., Rizk, Emanuelle, Rose, Sharon, Zhu, Kuixi, Lau, Branden, Fullerton, Benjamin T., Pradhan, Jaya, Moore, Michael, Srivastava, Ayush C., Singer, Giselle, Gartrell, Robyn, Chang, Rui, Geskin, Larisa J., Saenger, Yvonne M., Goldenberg, Gary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062619/ https://www.ncbi.nlm.nih.gov/pubmed/33888854 http://dx.doi.org/10.1038/s41598-021-88424-z |
Ejemplares similares
-
Safety, efficacy, and patient acceptability of imiquimod for topical treatment of actinic keratoses
por: Caperton, Caroline, et al.
Publicado: (2011) -
Visualization and Treatment of Subclinical Actinic Keratoses with Topical Imiquimod 5% Cream: An Observational Study
por: Kopera, Daisy, et al.
Publicado: (2014) -
Effective Combination of Photodynamic Therapy and Imiquimod 5% Cream in the Treatment of Actinic Keratoses: Three Cases
por: Held, Laura, et al.
Publicado: (2013) -
Optimal treatment of actinic keratoses
por: Uhlenhake, Elizabeth E
Publicado: (2013) -
Diclofenac gel in the treatment of actinic keratoses
por: Nelson, Christopher G
Publicado: (2011)